Literature DB >> 23245546

Growth hormone STAT5-mediated signaling and its modulation in mice liver during the growth period.

Carolina S Martinez1, Verónica G Piazza, Laura D Ratner, Marina N Matos, Lorena González, Susana B Rulli, Johanna G Miquet, Ana I Sotelo.   

Abstract

Postnatal growth exhibits two instances of rapid growth in mice: the first is perinatal and independent of growth hormone (GH), the second is peripuberal and GH-dependent. Signal transducer and activator of transcription 5b (STAT5b) is the main GH-signaling mediator and it is related to IGF1 synthesis and somatic growth. The aim of this work was to assess differential STAT5 sensitivity to GH during the growth period in mouse liver of both sexes. Three representative ages were selected: 1-week-old animals, in the GH-independent phase of growth; 2.5-week-old mice, at the onset of the GH-dependent phase of growth; and 9-week-old young adults. GH-signaling mediators were assessed by immunoblotting, quantitative RT-PCR and immunohistochemistry. GH-induced STAT5 phosphorylation is low at one-week and maximal at 2.5-weeks of age when compared to young adults, accompanied by higher protein content at the onset of growth. Suppressor CIS and phosphatase PTP1B exhibit high levels in one-week animals, which gradually decline, while SOCS2 and SOCS3 display higher levels at adulthood. Nuclear phosphorylated STAT5 is low in one-week animals while in 2.5-week animals it is similar to 9-week control; expression of SOCS3, an early response GH-target gene, mimics this pattern. STAT5 coactivators glucocorticoid receptor (GR) and hepatic nuclear factor 1 (HNF1) abundance is higher in adulthood. Therefore, GH-induced STAT5 signaling presents age-dependent activity in liver, with its maximum coinciding with the onset of GH-dependent phase of growth, accompanied by an age-dependent variation of modulating factors. This work contributes to elucidate the molecular mechanisms implicated in GH responsiveness during growth.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23245546     DOI: 10.1016/j.ghir.2012.11.002

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  11 in total

1.  GH/STAT5 signaling during the growth period in livers of mice overexpressing GH.

Authors:  Carolina S Martinez; Verónica G Piazza; María E Díaz; Ravneet K Boparai; Oge Arum; María C Ramírez; Lorena González; Damasia Becú-Villalobos; Andrzej Bartke; Daniel Turyn; Johanna G Miquet; Ana I Sotelo
Journal:  J Mol Endocrinol       Date:  2015-02-17       Impact factor: 5.098

2.  Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone.

Authors:  Johanna G Miquet; Thomas Freund; Carolina S Martinez; Lorena González; María E Díaz; Giannina P Micucci; Elsa Zotta; Ravneet K Boparai; Andrzej Bartke; Daniel Turyn; Ana I Sotelo
Journal:  Cell Cycle       Date:  2013-02-21       Impact factor: 4.534

3.  Mitogenic signaling pathways in the liver of growth hormone (GH)-overexpressing mice during the growth period.

Authors:  Carolina S Martinez; Verónica G Piazza; Lorena González; Yimin Fang; Andrzej Bartke; Daniel Turyn; Johanna G Miquet; Ana I Sotelo
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

4.  Protective and therapeutic effects of two novel strains of Lactobacilli on diabetes-associated disorders induced by a high level of fructose.

Authors:  Naif ALSuhaymi; Ahmed M Darwish; Abd El-Nasser Khattab
Journal:  Mol Biol Rep       Date:  2021-06-02       Impact factor: 2.316

5.  Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer.

Authors:  E Letellier; M Schmitz; K Baig; N Beaume; C Schwartz; S Frasquilho; L Antunes; N Marcon; P V Nazarov; L Vallar; J Even; S Haan
Journal:  Br J Cancer       Date:  2014-07-15       Impact factor: 7.640

6.  Central IGF1 improves glucose tolerance and insulin sensitivity in mice.

Authors:  Hao Hong; Zhen-Zhong Cui; Lu Zhu; Shu-Ping Fu; Mario Rossi; Ying-Hong Cui; Bing-Mei Zhu
Journal:  Nutr Diabetes       Date:  2017-12-19       Impact factor: 5.097

7.  Growth Hormone Did Not Activate Its Intracellular Signaling Molecules in Rats' Liver Hepatocytes During Early Life Period.

Authors:  Ruonan Li; Pan Hong; Hainan Lan; Xin Zheng
Journal:  Int J Endocrinol Metab       Date:  2018-06-23

Review 8.  Update on the synergistic effect of HSL and insulin in the treatment of metabolic disorders.

Authors:  Yu-Long Lan; Jia-Cheng Lou; Wen Lyu; Bo Zhang
Journal:  Ther Adv Endocrinol Metab       Date:  2019-09-20       Impact factor: 3.565

9.  Disruption of STAT5b-Regulated Sexual Dimorphism of the Liver Transcriptome by Diverse Factors Is a Common Event.

Authors:  Keiyu Oshida; Naresh Vasani; David J Waxman; J Christopher Corton
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

10.  JAK2-STAT5 signaling is insensitive to porcine growth hormone (pGH) in hepatocytes of neonatal pig.

Authors:  Yang Yu-Jiang; Zheng Xin; Lan Hai-Nan
Journal:  Anim Cells Syst (Seoul)       Date:  2020-04-27       Impact factor: 1.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.